Neprofarm takes issue with borderlines group
This article is powered by OTC Bulletin & The Rose Sheet
Executive Summary
Dutch self-care industry association Neprofarm has called for the Netherland’s recently-formalised advisory group on so-called ‘borderlines’ – those products and substances which exist in a regulatory grey area between foods, medicines, cosmetics and biocides – to be opened up to public scrutiny.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.
Novartis Hires Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.